Home › Funds › MUTUAL FUND SERIES TRUST › Eventide Healthcare & Life Sciences Fund
Fund family: MUTUAL FUND SERIES TRUST · Filed by MUTUAL FUND SERIES TRUST (CIK 1355064) · SEC series S000039514
Share classes and tickers: ETAHX (C000121707), ETCHX (C000121708), ETIHX (C000121710), ETNHX (C000121709)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 419 with, 0 against, 1 abstentions (not counted as with management); 5 items carried no recommendation. Shareholder proposals: 0 FOR, 0 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as MUTUAL FUND SERIES TRUST’s manager page (12,253 ballot items across 22 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | MUTUAL FUND SERIES TRUST | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 99.7% | 394 | 93.0% | 10,912 |
| Backed environmental and social shareholder proposals at US companies | n/a | 0 | 17.7% | 334 |
Each ballot item this fund voted is set against the votes of the other MUTUAL FUND SERIES TRUST funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted the same way as most MUTUAL FUND SERIES TRUST funds on all 10 items where a comparison was possible.
The same votes as “with management” above, by the sector of the company voted on. 71.2% of this fund’s 420 such votes could be given a sector; the other 121 (28.8%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Health Care | 288 | 0 | 0.0% |
| Industrials | 11 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 225 | 0 |
| Audit-related | 53 | 0 |
| Say-on-Pay | 49 | 0 |
| Compensation | 38 | 0 |
| Corporate Governance | 31 | 0 |
| Capital Structure | 29 | 0 |
| Extraordinary Transactions | 6 | 0 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Guardant Health, Inc. | June 17, 2026 | $101M | 5 | 0 |
| Kymera Therapeutics, Inc. | June 24, 2026 | $78M | 6 | 0 |
| Mirum Pharmaceuticals, Inc. | June 15, 2026 | $56M | 5 | 0 |
| Vaxcyte, Inc. | June 15, 2026 | $51M | 5 | 0 |
| MBX Biosciences, Inc. | June 4, 2026 | $47M | 3 | 0 |
| Insmed Incorporated | May 13, 2026 | $45M | 4 | 0 |
| Revolution Medicines, Inc. | June 18, 2026 | $43M | 4 | 0 |
| Amylyx Pharmaceuticals, Inc. | June 4, 2026 | $42M | 4 | 0 |
431 ballot items at 57 meetings in 2025-2026. Download all votes (CSV)
In the 2025-2026 proxy season, Eventide Healthcare & Life Sciences Fund (ETAHX) voted at 57 shareholder meetings of 56 companies, on 431 ballot items in all. Where management made a recommendation, the fund followed it on 99.8% of the items and voted against it 0 times. It voted FOR the board's own proposals more often than MUTUAL FUND SERIES TRUST's funds as a whole (99.7% against 93.0%). It voted the same way as most MUTUAL FUND SERIES TRUST funds on every item where a comparison was possible.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of MUTUAL FUND SERIES TRUST’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.